Preliminary results of the phase 2 study of zanubrutinib in patients with previously treated B-cell malignancies intolerant to ibrutinib and/or acalabrutinib.

被引：7
|
作者：
Shadman, Mazyar
Sharman, Jeff Porter
Levy, Moshe Y.
Porter, Ryan
Zafar, Syed Farhan
Burke, John M.
Chaudhry, Arvind
Freeman, Benjamin Bruce
Misleh, Jamal Ghazi
Yimer, Habte Aragaw
Cultrera, Jennifer L.
Guthrie, Troy H.
Kingsley, Ed
Rao, Subramanya S.
Chen, Dih-Yih
Cohen, Aileen
Feng, Shibao
Huang, Jane
Flinn, Ian
机构：
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[2] Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA
[3] Baylor Charles A Sammons Canc Ctr, Texas Oncol, Dallas, TX USA
[4] SSM Hlth Dean Med Grp, Madison, WI USA
[5] Florida Canc Specialists & Res Inst, Ft Myers, FL USA
[6] Rocky Mt Canc Ctr, Aurora, CO USA
[7] Summit Canc Ctr, Spokane, WA USA
[8] Summit Med Grp, Florham Pk, NJ USA
[9] Med Oncol Hematol Consultants PA, Newark, DE USA
[10] Texas Oncol Tyler, Tyler, TX USA
[11] Florida Canc Specialists & Res Inst, Leesburg, FL USA
[12] 21st Century Oncol, Jacksonville, FL USA
[13] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[14] Alpha Med Phys Grp, Tinley Pk, IL USA
[15] BeiGene USA Inc, San Mateo, CA USA
[16] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e19506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19506
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A phase 2 study of zanubrutinib in previously treated B-cell malignancies intolerant to ibrutinib and/or acalabrutinib: preliminary results for patients with CLL/SLL
    Shadman, Mazyar
    Burke, John M.
    Zafar, Syed F.
    Misleh, Jamal
    Rao, Subramanya S.
    Farber, Charles M.
    Cohen, Aileen
    Crescenzo, Rocco
    By, Kunthel
    Flinn, Ian
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2023, 64 : S66 - S66
  • [2] Phase 2 Study of Zanubrutinib in Patients with Relapsed/Refractory B-Cell Malignancies Intolerant to Ibrutinib/Acalabrutinib
    Shadman, Mazyar
    Sharman, Jeff P.
    Levy, Moshe Y.
    Misleh, Jamal
    Zafar, Syed F.
    Freeman, Benjamin B.
    Burke, John M.
    Cultrera, Jennifer L.
    Yimer, Habte A.
    Chen, Dih-Yih
    Zhang, Xiaoping
    Cohen, Aileen
    Ro, Sunhee
    Huang, Jane
    Flinn, Ian W.
    BLOOD, 2020, 136
  • [3] Genomic Landscape of Ibrutinib- and/or Acalabrutinib-intolerant Patients with B-cell Malignancies Treated with Zanubrutinib in a Phase 2 Study
    Xu, Linlin
    Shadman, Mazyar
    Flinn, Ian W.
    Levy, Moshe
    Porter, Ryan
    Burke, John M.
    Zafar, Syed F.
    Cultrera, Jennifer L.
    Misleh, Jamal
    Kingsley, Edwin C.
    Yimer, Habte A.
    Freeman, Benjamin B.
    Chaudhry, Arvind
    Tumula, Praveen K.
    Gandhi, Mitul
    Crescenzo, Rocco J.
    By, Kunthel
    Cohen, Aileen Cleary
    Idoine, Adam
    Manda, Sudhir
    Sharman, Jeff P.
    BLOOD, 2023, 142
  • [4] Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
    Xu, Linlin
    Shadman, Mazyar
    Flinn, Ian W.
    Levy, Moshe Y.
    Porter, Ryan
    Burke, John M.
    Zafar, Syed F.
    Cultrera, Jennifer L.
    Misleh, Jamal
    Kingsley, Edwin C.
    Yimer, Habte A.
    Freeman, Benjamin
    Chaudhry, Arvind
    Tumula, Praveen K.
    Gandhi, Mitul D.
    Crescenzo, Rocco
    By, Kunthel
    Cohen, Aileen
    Chen, Dih Yih
    Idoine, Adam
    Manda, Sudhir
    Sharman, Jeff P.
    Ramakrishnan, Vanitha
    HAEMATOLOGICA, 2024, 109 (07) : 2284 - 2289
  • [5] Zanubrutinib in acalabrutinib-intolerant patients with B-cell malignancies
    Crescenzo, Rocco
    Shadman, Mazyar
    Flinn, Ian W.
    Kingsley, Edwin C.
    Freeman, Benjamin
    Levy, Moshe Y.
    Holmes, Houston
    Farber, Charles M.
    Chaudhry, Arvind
    Idoine, Adam
    Zhang, Xiaoping
    Cohen, Aileen
    By, Kunthel
    Sharman, Jeff P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 84 - 85
  • [6] Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
    Xu, Linlin
    Shadman, Mazyar
    Flinn, Ian W.
    Levy, Moshe Y.
    Porter, Ryan
    Burke, John M.
    Zafar, Syed F.
    Cultrera, Jennifer L.
    Misleh, Jamal
    Kingsley, Edwin C.
    Yimer, Habte A.
    Freeman, Benjamin
    Chaudhry, Arvind
    Tumula, Praveen K.
    Gandhi, Mitul D.
    Crescenzo, Rocco
    By, Kunthel
    Cohen, Aileen
    Chen, Dih Yih
    Idoine, Adam
    Manda, Sudhir
    Sharman, Jeff P.
    Ramakrishnan, Vanitha
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2284 - 2289
  • [7] Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies
    Shadman, Mazyar
    Flinn, Ian W.
    Kingsley, Edwin C.
    Freeman, Benjamin B.
    Levy, Moshe
    Farber, Charles M.
    D'Olimpio, James
    Cultrera, Jennifer L.
    Zhang, Ben
    Crescenzo, Rocco J.
    Idoine, Adam
    Zhang, Xiaoping
    By, Kunthel
    Sharman, Jeff P.
    BLOOD, 2023, 142
  • [8] Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies
    Shadman, Mazyar
    Flinn, Ian W.
    Kingsley, Edwin C.
    Freeman, Benjamin
    Levy, Moshe Yair
    Holmes, Houston
    Farber, Charles M.
    Chaudhry, Arvind
    Crescenzo, Rocco
    Idoine, Adam
    Zhang, Xiaoping
    Cohen, Aileen
    By, Kunthel
    Huang, Jane
    Sharman, Jeff P.
    BLOOD, 2022, 140 : 3655 - 3657
  • [9] Zanubrutinib is Well Tolerated and Effective in Acalabrutinib-Intolerant Patients with B-cell Malignancies
    Shadman, Mazyar
    Flinn, Ian W.
    Levy, Moshe Y.
    Freeman, Benjamin B.
    Zhang, Ben
    Burke, John M.
    Cultrera, Jennifer L.
    Yimer, Habte A.
    Kingsley, Edwin C.
    Farber, Charles M.
    D'Olimpio, James
    Yao, Hui
    Idoine, Adam
    An, Qi
    Sharman, Jeff P.
    BLOOD, 2024, 144 : 4632 - 4633
  • [10] Phase 2 Study of Zanubrutinib in BTK Inhibitor-Intolerant Patients (Pts) with Relapsed/Refractory B-Cell Malignancies
    Shadman, Mazyar
    Flinn, Ian W.
    Levy, Moshe Y.
    Porter, Ryan
    Burke, John M.
    Cultrera, Jennifer L.
    Misleh, Jamal
    Zafar, Syed F.
    Freeman, Benjamin
    Rao, Subramanya S.
    Yimer, Habte
    Chaudhry, Arvind
    Gandhi, Mitul D.
    Guthrie, Troy H.
    Kingsley, Edwin
    Tumula, Praveen K.
    Manda, Sudhir
    Chen, Dih-Yih
    Cohen, Aileen
    By, Kunthel
    Xu, Linlin
    Liu, Ye
    Sharman, Jeff P.
    BLOOD, 2021, 138
12345